Immunotherapy offers new options for some cancer patients
15 Minuten
Podcast
Podcaster
Beschreibung
vor 7 Jahren
Stephen Graziano, MD (photo by Robert Mescavage) Stephen Graziano,
MD (photo by Robert Mescavage) A growing number of medications that
influence the body's immune system to help fight cancer are
available to patients with certain types of cancer. A growing
number of medications that influence the body's immune system to
help fight cancer are available to patients with certain types of
cancer. Stephen Graziano, MD, Stephen Graziano, MD, explains the
history of immunotherapy and recent advances that are extending the
lives of some patients. Graziano is Upstate's chief of adult
hematology and oncology, with expertise in lung cancer. He tells
about clinical trials underway at Upstate that make use of
immunotherapy medications and discusses the risks and side effects
of these drugs, which are not appropriate for all patients.
explains the history of immunotherapy and recent advances that are
extending the lives of some patients. Graziano is Upstate's chief
of adult hematology and oncology, with expertise in lung cancer. He
tells about clinical trials underway at Upstate that make use of
immunotherapy medications and discusses the risks and side effects
of these drugs, which are not appropriate for all patients.
MD (photo by Robert Mescavage) A growing number of medications that
influence the body's immune system to help fight cancer are
available to patients with certain types of cancer. A growing
number of medications that influence the body's immune system to
help fight cancer are available to patients with certain types of
cancer. Stephen Graziano, MD, Stephen Graziano, MD, explains the
history of immunotherapy and recent advances that are extending the
lives of some patients. Graziano is Upstate's chief of adult
hematology and oncology, with expertise in lung cancer. He tells
about clinical trials underway at Upstate that make use of
immunotherapy medications and discusses the risks and side effects
of these drugs, which are not appropriate for all patients.
explains the history of immunotherapy and recent advances that are
extending the lives of some patients. Graziano is Upstate's chief
of adult hematology and oncology, with expertise in lung cancer. He
tells about clinical trials underway at Upstate that make use of
immunotherapy medications and discusses the risks and side effects
of these drugs, which are not appropriate for all patients.
Weitere Episoden
16 Minuten
vor 5 Jahren
16 Minuten
vor 5 Jahren
In Podcasts werben
Kommentare (0)